Date: April 20, 2021
Time: 11:00am (PST), 2:00pm (EST)
Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information required to release or hold products. Despite the difficulties in establishing a coherent definition for bacterial species and the long time-to-results, phenotypic and biochemical tests are still widely used and recognized. MALDI-TOF mass spectrometry has significantly changed the identification procedure and has to be extensively validated following AOAC and ISO 16140-6 guidelines. The Bruker MALDI Biotyper® is now regarded as a reliable and accurate alternative to quickly identify or routinely confirm systematic perspectives. Contract laboratories are beginning to adopt the Bruker MALDI Biotyper® as an efficient and effective alternative for identification and confirmation analysis in a routine laboratory setting.
- Understand the perspective of contract laboratories and their role in routine testing, identification and confirmation of microorganisms.
- Describe the process for validation of the MALDI-TOF and why this is necessary.
- Explain how MALDI-TOF technology can improve the characterization and confirmation of microbiology isolates.
- List the advantages of the Bruker MALDI Biotyper over the traditional identification methods such as biochemicals and molecular.
Not for use in clinical diagnostic procedures.
Please contact your local representative for availability in your country.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.